{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:43:55Z","timestamp":1773445435733,"version":"3.50.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Abbott Vascular Int."},{"name":"Amgen Cardiovascular"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol Myers Squibb and Pfizer Alliance"},{"name":"Daiichi Sankyo Europe GmbH"},{"name":"Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company"},{"name":"Gedeon Richter Plc."},{"name":"Menarini Int. Op."},{"name":"MSD-Merck & Co."},{"name":"Novartis Pharma AG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Rhythm control management in patients with atrial fibrillation (AF) may be unequal across Europe. The aim of this study was to investigate how selective the patient cohort referred for AF ablation is, as compared to the general AF population in Europe, and to describe the governing mechanisms for such selection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Descriptive comparative statistical analyses of the baseline characteristics were performed between the cohorts of Atrial Fibrillation Ablation Long-Term (ESC EORP AFA-LT) registry, designed to provide a picture of contemporary real-world AF ablation, and the AF population from the AF-General (ESC EORP AF-Gen) pilot registry. Data collection was performed using a web-based system. In the AFA and in the Atrial Fibrillation General (AFG) pilot registries, 3593 and 3049 patients were enrolled, respectively. Patients who underwent AF ablation were younger, more commonly male, and had significantly less comorbidities. Atrial Fibrillation Ablation patients often presented without comorbidities, resulting in a lower risk of stroke (CHA2DS2-VASc \u22655: 2.9% vs. 24.5%, all P\u2009&amp;lt;\u20090.001) and bleeding (HAS-BLED \u22652: 8.5% vs. 40.5%, P\u2009&amp;lt;\u20090.001) but with European Heart Rhythm Association (EHRA) scores &amp;gt;1 and more prevalent AF-related symptoms such as palpitations, fatigue, and weakness (all P\u2009&amp;lt;\u20090.001) as compared to the general AF patients. Atrial Fibrillation Ablation patients were significantly more often male, had higher left ventricular ejection fraction (59.5% vs. 52.4%) and smaller left atrial size on echocardiogram (P\u2009&amp;lt;\u20090.001 each).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The comparison of the patient cohorts in the AFA and AFG registries showed that AF ablation in European clinical practice is mostly performed in relatively young, symptomatic and relatively healthy patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euz291","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T23:28:19Z","timestamp":1571873299000},"page":"250-258","source":"Crossref","is-referenced-by-count":11,"title":["Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0122-7130","authenticated-orcid":false,"given":"Roland Richard","family":"Tilz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center, Medical Clinic II, University Hospital Schleswig-Holstein, Ratzeburger Allee 160, 23538 Luebeck, Germany"},{"name":"Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site, Hamburg\/Kiel\/L\u00fcbeck, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-4956","authenticated-orcid":false,"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-6393","authenticated-orcid":false,"given":"Elena","family":"Arbelo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Institute, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d\u2019Investigaci\u00f3 August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-3903","authenticated-orcid":false,"given":"Carina","family":"Blomstr\u00f6m-Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands"},{"name":"Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0197","authenticated-orcid":false,"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham and SWBH and UHB NHS Trusts, Birmingham, Great Britain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Temporelli","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme (EORP), ESC, Sophia-Antipolis, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R","family":"Roberts","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Trust, Southampton, Great Britain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen","family":"Pehrson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, Great Britain"},{"name":"Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Brugada","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Hospital Cl\u00ednic Pediatric Arrhythmia Unit, Hospital Sant Joan de D\u00e9u University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care&Research, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Atrial Fibrillation Ablation and Atrial Fibrillation Registries Investigators Groups","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"2020020703531016300_euz291-B1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/europace\/eux275","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"2020020703531016300_euz291-B2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/europace\/euv439","article-title":"Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study","volume":"18","author":"Teunissen","year":"2016","journal-title":"Europace"},{"key":"2020020703531016300_euz291-B3","doi-asserted-by":"crossref","first-page":"e005250.","DOI":"10.1161\/CIRCEP.117.005250","article-title":"Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation","volume":"11","author":"Tilz","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020020703531016300_euz291-B4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2012.04.060","article-title":"Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy","volume":"60","author":"Tilz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2020020703531016300_euz291-B5","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"2020020703531016300_euz291-B6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"2020020703531016300_euz291-B7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jce.13439","article-title":"Geographic and racial representation and reported success rates of studies of catheter ablation for atrial fibrillation: findings from the SMASH-AF meta-analysis study cohort","volume":"29","author":"Leef","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2020020703531016300_euz291-B8","first-page":"1303","article-title":"Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry","volume":"38","author":"Arbelo","year":"2017","journal-title":"Eur Heart J"},{"key":"2020020703531016300_euz291-B9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2020020703531016300_euz291-B10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"2020020703531016300_euz291-B11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJM199107253250401","article-title":"Differences in the use of procedures between women and men hospitalized for coronary heart disease","volume":"325","author":"Ayanian","year":"1991","journal-title":"N Engl J Med"},{"key":"2020020703531016300_euz291-B12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/jama.298.13.1525","article-title":"Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure","volume":"298","author":"Hernandez","year":"2007","journal-title":"JAMA"},{"key":"2020020703531016300_euz291-B13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jacc.2005.07.007","article-title":"Gender-related differences in atrial fibrillation","volume":"46","author":"Kerr","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2020020703531016300_euz291-B14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjcard.2016.09.049","article-title":"Gender-specific differences for risk of disability and death in atrial fibrillation-related stroke","volume":"119","author":"Martin","year":"2017","journal-title":"Am J Cardiol"},{"key":"2020020703531016300_euz291-B15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.hrthm.2009.10.025","article-title":"Outcomes and complications of catheter ablation for atrial fibrillation in females","volume":"7","author":"Patel","year":"2010","journal-title":"Heart Rhythm"},{"key":"2020020703531016300_euz291-B16","doi-asserted-by":"crossref","first-page":"e006204.","DOI":"10.1161\/CIRCEP.118.006204","article-title":"Impact of female sex on clinical outcomes in the FIRE AND ICE trial of catheter ablation for atrial fibrillation","volume":"11","author":"Kuck","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2020020703531016300_euz291-B17","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/eurheartj\/ehu354","article-title":"Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)","volume":"35","author":"Darkner","year":"2014","journal-title":"Eur Heart J"},{"key":"2020020703531016300_euz291-B18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/22\/2\/250\/32360007\/euz291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/22\/2\/250\/32360007\/euz291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:53:36Z","timestamp":1581047616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/22\/2\/250\/5640260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,26]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz291","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,11,26]]}}}